Literature DB >> 20458194

Comorbidities of obsessive and compulsive symptoms in Huntington's disease.

Karen E Anderson1, Carissa R Gehl, Karen S Marder, Leigh J Beglinger, Jane S Paulsen.   

Abstract

Although current reports document a high rate of obsessive and compulsive symptoms (O/Cs) in Huntington's disease (HD), there have been no studies published that have made an attempt to identify comorbidities of O/Cs in HD. We examined O/Cs in 1642 individuals with a diagnosis of HD. Of those endorsing significant O/Cs (27.2%), nearly one-quarter reported obtaining treatment for obsessive compulsive disorder. Individuals with HD and O/Cs were older, had poorer functioning, and a longer duration of illness than those without O/Cs. Individuals with HD and O/Cs endorsed significantly higher psychiatric comorbidities of depression, suicidal ideation, aggression, delusions, and hallucinations. Participants with the most severe O/Cs and worse performance on the Stroop task, a measure of executive function. Clinicians should be aware that patients with HD and O/Cs might have a somewhat different clinical picture from those without, and may require a specialized treatment plan.

Entities:  

Mesh:

Year:  2010        PMID: 20458194      PMCID: PMC3164360          DOI: 10.1097/NMD.0b013e3181da852a

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  31 in total

1.  Late-life obsessive-compulsive disorder and Huntington's disease.

Authors:  A Scicutella
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2000       Impact factor: 2.198

2.  Cognitive correlates of obsessive and compulsive symptoms in Huntington's disease.

Authors:  K E Anderson; E D Louis; Y Stern; K S Marder
Journal:  Am J Psychiatry       Date:  2001-05       Impact factor: 18.112

3.  Regional and progressive thinning of the cortical ribbon in Huntington's disease.

Authors:  H D Rosas; A K Liu; S Hersch; M Glessner; R J Ferrante; D H Salat; A van der Kouwe; B G Jenkins; A M Dale; B Fischl
Journal:  Neurology       Date:  2002-03-12       Impact factor: 9.910

4.  Fluoxetine in the treatment of Huntington's disease.

Authors:  N De Marchi; F Daniele; M A Ragone
Journal:  Psychopharmacology (Berl)       Date:  2001-01-01       Impact factor: 4.530

5.  Striatal volume loss in HD as measured by MRI and the influence of CAG repeat.

Authors:  H D Rosas; J Goodman; Y I Chen; B G Jenkins; D N Kennedy; N Makris; M Patti; L J Seidman; M F Beal; W J Koroshetz
Journal:  Neurology       Date:  2001-09-25       Impact factor: 9.910

6.  Rate of functional decline in Huntington's disease. Huntington Study Group.

Authors:  K Marder; H Zhao; R H Myers; M Cudkowicz; E Kayson; K Kieburtz; C Orme; J Paulsen; J B Penney; E Siemers; I Shoulson
Journal:  Neurology       Date:  2000-01-25       Impact factor: 9.910

7.  Neuropsychiatric aspects of Huntington's disease.

Authors:  J S Paulsen; R E Ready; J M Hamilton; M S Mega; J L Cummings
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

8.  Gilles de la Tourette's syndrome with and without obsessive-compulsive disorder compared with obsessive-compulsive disorder without tics: which symptoms discriminate?

Authors:  D C Cath; P Spinhoven; T C van Woerkom; B J van de Wetering; C A Hoogduin; A D Landman; R A Roos; H G Rooijmans
Journal:  J Nerv Ment Dis       Date:  2001-04       Impact factor: 2.254

Review 9.  Cognitive and neurobiological findings in obsessive-compulsive disorder.

Authors:  Karen E Anderson; Cary R Savage
Journal:  Psychiatr Clin North Am       Date:  2004-03

10.  Detection of Huntington's disease decades before diagnosis: the Predict-HD study.

Authors:  J S Paulsen; D R Langbehn; J C Stout; E Aylward; C A Ross; M Nance; M Guttman; S Johnson; M MacDonald; L J Beglinger; K Duff; E Kayson; K Biglan; I Shoulson; D Oakes; M Hayden
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-12-20       Impact factor: 10.154

View more
  7 in total

Review 1.  Therapy in Huntington's disease: where are we?

Authors:  Martha A Nance
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

2.  Deficits in stepping response time are associated with impairments in balance and mobility in people with Huntington disease.

Authors:  Allon Goldberg; Stacey L Schepens; Shawna M E Feely; James Y Garbern; Lindsey J Miller; Carly E Siskind; Gerry E Conti
Journal:  J Neurol Sci       Date:  2010-11-15       Impact factor: 3.181

3.  Depression in the early stages of Huntington disease.

Authors:  Eric A Epping; Jane S Paulsen
Journal:  Neurodegener Dis Manag       Date:  2011-10-01

4.  Structural brain correlates of irritability and aggression in early manifest Huntington's disease.

Authors:  Saul Martinez-Horta; Frederic Sampedro; Andrea Horta-Barba; Jesús Perez-Perez; Javier Pagonabarraga; Beatriz Gomez-Anson; Jaime Kulisevsky
Journal:  Brain Imaging Behav       Date:  2021-02       Impact factor: 3.978

5.  An International Survey-based Algorithm for the Pharmacologic Treatment of Obsessive-Compulsive Behaviors in Huntington's Disease.

Authors:  Karen Anderson; David Craufurd; Mary C Edmondson; Nathan Goodman; Mark Groves; Erik van Duijn; Daniel P van Kammen; Lavonne Goodman
Journal:  PLoS Curr       Date:  2011-09-20

Review 6.  Neuropsychiatric Burden in Huntington's Disease.

Authors:  Ricardo Augusto Paoli; Andrea Botturi; Andrea Ciammola; Vincenzo Silani; Cecilia Prunas; Claudio Lucchiari; Elisa Zugno; Elisabetta Caletti
Journal:  Brain Sci       Date:  2017-06-16

7.  Obsessive-Compulsive and Perseverative Behaviors in Huntington's Disease.

Authors:  Mayke Oosterloo; David Craufurd; Hanneke Nijsten; Erik van Duijn
Journal:  J Huntingtons Dis       Date:  2019
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.